Radiation Oncology Journal

The Korean Society for Radiation Oncology (대한방사선종양학회)
권호 표지
DOI QR코드

DOI QR Code

Dosimetric comparison of axilla and groin radiotherapy techniques for high-risk and locally advanced skin cancer

  • Mattes, Malcolm D. (Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center) ;
  • Zhou, Ying (Department of Medical Physics, Memorial Sloan Kettering Cancer Center) ;
  • Berry, Sean L. (Department of Medical Physics, Memorial Sloan Kettering Cancer Center) ;
  • Barker, Christopher A. (Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center)
  • Received : 2015.12.11
  • Accepted : 2016.03.10
  • Published : 2016.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Radiation therapy targeting axilla and groin lymph nodes improves regional disease control in locally advanced and high-risk skin cancers. However, trials generally used conventional two-dimensional radiotherapy (2D-RT), contributing towards relatively high rates of side effects from treatment. The goal of this study is to determine if three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), or volumetric-modulated arc therapy (VMAT) may improve radiation delivery to the target while avoiding organs at risk in the clinical context of skin cancer regional nodal irradiation. Materials and Methods: Twenty patients with locally advanced/high-risk skin cancers underwent computed tomography simulation. The relevant axilla or groin planning target volumes and organs at risk were delineated using standard definitions. Paired t-tests were used to compare the mean values of several dose-volumetric parameters for each of the 4 techniques. Results: In the axilla, the largest improvement for 3D-CRT compared to 2D-RT was for homogeneity index (13.9 vs. 54.3), at the expense of higher lung $V_{20}$ (28.0% vs. 12.6%). In the groin, the largest improvements for 3D-CRT compared to 2D-RT were for anorectum $D_{max}$ (13.6 vs. 38.9 Gy), bowel $D_{200cc}$ (7.3 vs. 23.1 Gy), femur $D_{50}$ (34.6 vs. 57.2 Gy), and genitalia $D_{max}$ (37.6 vs. 51.1 Gy). IMRT had further improvements compared to 3D-CRT for humerus $D_{mean}$ (16.9 vs. 22.4 Gy), brachial plexus $D_5$ (57.4 vs. 61.3 Gy), bladder $D_5$ (26.8 vs. 36.5 Gy), and femur $D_{50}$ (18.7 vs. 34.6 Gy). Fewer differences were observed between IMRT and VMAT. Conclusion: Compared to 2D-RT and 3D-CRT, IMRT and VMAT had dosimetric advantages in the treatment of nodal regions of skin cancer patients.

Keywords

References

  1. Burmeister BH, Henderson MA, Ainslie J, et al. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial. Lancet Oncol 2012;13:589-97. https://doi.org/10.1016/S1470-2045(12)70138-9
  2. Jouary T, Leyral C, Dreno B, et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol 2012;23:1074-80. https://doi.org/10.1093/annonc/mdr318
  3. O'Hara J, Ferlito A, Takes RP, et al. Cutaneous squamous cell carcinoma of the head and neck metastasizing to the parotid gland: a review of current recommendations. Head Neck 2011;33:1789-95. https://doi.org/10.1002/hed.21583
  4. Mendenhall WM, Mendenhall CM, Werning JW, Reith JD, Mendenhall NP. Cutaneous angiosarcoma. Am J Clin Oncol 2006;29:524-8. https://doi.org/10.1097/01.coc.0000227544.01779.52
  5. Burmeister BH, Mark Smithers B, Burmeister E, et al. A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma- Trans Tasman Radiation Oncology Group (TROG) Study 96.06. Radiother Oncol 2006;81:136-42. https://doi.org/10.1016/j.radonc.2006.10.001
  6. Veldeman L, Madani I, Hulstaert F, De Meerleer G, Mareel M, De Neve W. Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies. Lancet Oncol 2008;9:367-75. https://doi.org/10.1016/S1470-2045(08)70098-6
  7. Li XA, Tai A, Arthur DW, et al. Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study. Int J Radiat Oncol Biol Phys 2009;73:944-51. https://doi.org/10.1016/j.ijrobp.2008.10.034
  8. Myerson RJ, Garofalo MC, El Naqa I, et al. Elective clinical target volumes for conformal therapy in anorectal cancer: a RTOG consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009;74:824-30. https://doi.org/10.1016/j.ijrobp.2008.08.070
  9. Kong FM, Ritter T, Quint DJ, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442-57. https://doi.org/10.1016/j.ijrobp.2010.07.1977
  10. Gay HA, Barthold HJ, O'Meara E, et al. Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas. Int J Radiat Oncol Biol Phys 2012;83:e353-62. https://doi.org/10.1016/j.ijrobp.2012.01.023
  11. Hall WH, Guiou M, Lee NY, et al. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2008;72:1362-7. https://doi.org/10.1016/j.ijrobp.2008.03.004
  12. Galloway TJ, Amdur RJ, Liu C, Yeung AR, Mendenhall WM. Revisiting unnecessary larynx irradiation with whole-neck IMRT. Pract Radiat Oncol 2011;1:27-32. https://doi.org/10.1016/j.prro.2010.09.002
  13. Yi SK, Mak W, Yang CC, et al. Development of a standardized method for contouring the lumbosacral plexus: a preliminary dosimetric analysis of this organ at risk among 15 patients treated with intensity-modulated radiotherapy for lower gastrointestinal cancers and the incidence of radiationinduced lumbosacral plexopathy. Int J Radiat Oncol Biol Phys 2012;84:376-82. https://doi.org/10.1016/j.ijrobp.2011.11.074
  14. Koper PC, Stroom JC, van Putten WL, et al. Acute morbidity reduction using 3D-CRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys 1999;43:727-34. https://doi.org/10.1016/S0360-3016(98)00406-4
  15. Dearnaley DP, Khoo VS, Norman AR, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999;353:267-72. https://doi.org/10.1016/S0140-6736(98)05180-0
  16. Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z. Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 2005;63:765-71. https://doi.org/10.1016/j.ijrobp.2005.02.050
  17. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008;26:2085-92. https://doi.org/10.1200/JCO.2007.15.2488
  18. Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007;82:254-64. https://doi.org/10.1016/j.radonc.2006.12.008
  19. Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-9. https://doi.org/10.1200/JCO.2007.11.5501
  20. Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981-91. https://doi.org/10.1016/j.ijrobp.2006.06.013
  21. Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127-36. https://doi.org/10.1016/S1470-2045(10)70290-4
  22. Henderson MA, Burmeister BH, Ainslie J, et al. Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node field relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial. Lancet Oncol 2015;16:1049-60. https://doi.org/10.1016/S1470-2045(15)00187-4
  23. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991; 21:109-22.
  24. Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S10-9. https://doi.org/10.1016/j.ijrobp.2009.07.1754
  25. Kachnic LA, Winter K, Myerson RJ, et al. RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2013;86:27-33. https://doi.org/10.1016/j.ijrobp.2012.09.023
  26. Hallemeier CL, Garces YI, Neben-Wittich MA, et al. Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. Pract Radiat Oncol 2013;3:e71-7. https://doi.org/10.1016/j.prro.2012.06.003
  27. Radiation Therapy Oncology Group. RTOG protocol table [Internet]. Philadelphia, PA: Radiation Therapy Oncology Group; c2016 [cited 2016 Mar 18]. Available from: http://www.rtog.org/ClinicalTrials/ProtocolTable.aspx.

Cited by

  1. Treatment-plan evaluation using the dose quality factor (DQF) for dynamic conformal arc (DCA)-based radiosurgery on patients presenting with an intracranial tumor vol.69, pp.12, 2016, https://doi.org/10.3938/jkps.69.1834
  2. Dosimetric effects of sectional adjustments of collimator angles on volumetric modulated arc therapy for irregularly-shaped targets vol.12, pp.4, 2016, https://doi.org/10.1371/journal.pone.0174924
  3. Optimal collimator rotation based on the outline of multiple brain targets in VMAT vol.13, pp.None, 2016, https://doi.org/10.1186/s13014-018-1039-5